PAVmed Inc. — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Next earnings (estimated): Wed, April 1, 2026 — 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $52K | ↑+420.0% | — | — | — |
| 2025-09-30 | $5K | ↓-99.5% | $-5M | ↓-108.4% | -96880.0% |
| 2025-06-30 | $6K | — | $-12M | — | -78583.3% |
| 2025-03-31 | $8K | ↓-99.2% | $19M | ↑+275.2% | -68075.0% |
| 2024-12-31 | $10K | ↓-99.0% | — | — | — |
| 2024-09-30 | $996K | ↓-5.1% | $64M | — | -1162.4% |
| 2024-09-10 | — | — | — | — | — |
| 2024-06-30 | $979K | ↑+489.8% | $-11M | ↑+25.5% | -1397.8% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Revenue
$52K
↑+420.0% +$42K YoY
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 45 quarters
margin trajectory tells the operating-leverage storyGross Margin
-95.2%
Operating Margin↓-95717.6pts
-96880.0%
Net Margin↓-114125.8pts
-107660.0%
Go deeper
PAVM Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyPAVM Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics